Document Detail


Effects of L- and DL-carnitine on patients with impaired exercise tolerance.
MedLine Citation:
PMID:  7650839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We designed this study to determine whether orally administered L- and DL-carnitine can improve exercise tolerance in a group of patients with exercise intolerance. Nineteen patients with cardiac disease were randomly divided into 2 groups, an L-carnitine treatment group (n = 9) and a DL-carnitine treatment group (n = 10). Eight additional age-matched patients served as an untreated control group. Subjects in both carnitine treatment groups underwent cardiopulmonary exercise testing on a cycle ergometer in order to determine peak exercise time, peak oxygen uptake (VO2), lactate threshold (LT) and ventilatory threshold (VT) before and after the oral administration of 900 mg/day of L- or DL-carnitine for 2 weeks. Basal values of peak exercise time, peak VO2, LT and VT did not differ significantly among the 3 groups. Peak exercise time and peak VO2 tended to be increased in the L-carnitine treatment group, and tended to be decreased in the DL-carnitine treatment group. Both LT and VT (ml/kg/min) were significantly improved (LT: from 9.7 +/- 0.6 to 10.8 +/- 1.0, p < 0.05; VT: from 9.8 +/- 0.8 to 11.8 +/- 1.9, p < 0.02) by the administration of L-carnitine, while LT was significantly decreased (from 11.0 +/- 2.0 to 9.6 +/- 1.2, p < 0.05) and VT tended to be decreased by the administration of DL-carnitine (from 11.6 +/- 2.0 to 10.8 +/- 2.4). In the untreated control group, no significant changes were observed in the values of exercise tolerance between the 2 series of exercise testings. In neither group did carnitine modify hemodynamic parameters at rest or during exercise. In conclusion, this study demonstrated that L-carnitine increases and DL-carnitine decreases exercise tolerance in patients with impaired exercise tolerance.
Authors:
S Watanabe; R Ajisaka; T Masuoka; T Yamanouchi; T Saitou; M Toyama; N Takeyasu; K Sakamoto; Y Sugishita
Related Documents :
2737189 - Ventilatory threshold and mechanical efficiency in endurance runners.
3137329 - Effects of pedal rate on respiratory responses to incremental bicycle work.
9839719 - Resistive loading reduces ventilatory response to strychnine in anesthetized rabbits.
2287259 - Maximal inspiratory pressure following maximal exercise in trained and untrained subjects.
1185679 - Mean and breath-by-breath pattern of breathing in man during steady-state exercise.
2708199 - Human breathing pattern responses to loading with increased background impedance.
18491999 - Home-based exercise increases exercise capacity but not quality of life in people with ...
2764369 - Localization of the site of the bronchoconstrictor effects of leukotriene c4 compared w...
9627329 - Preictal spect in temporal lobe epilepsy: regional cerebral blood flow is increased pri...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Japanese heart journal     Volume:  36     ISSN:  0021-4868     ISO Abbreviation:  Jpn Heart J     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-09-26     Completed Date:  1995-09-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401175     Medline TA:  Jpn Heart J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  319-31     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Tsukuba, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Cardiac Output / drug effects
Carnitine / administration & dosage,  pharmacology*
Exercise Test
Exercise Tolerance / drug effects*
Female
Heart Diseases / drug therapy,  physiopathology
Hemodynamics / drug effects*
Humans
Lactates / metabolism
Lactic Acid
Male
Middle Aged
Oxygen Consumption / drug effects
Pyruvates / metabolism
Pyruvic Acid
Stereoisomerism
Chemical
Reg. No./Substance:
0/Lactates; 0/Pyruvates; 127-17-3/Pyruvic Acid; 50-21-5/Lactic Acid; 541-15-1/Carnitine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Accessory atrioventricular pathways and atrioventricular nodal reentrant tachycardia in teenagers. E...
Next Document:  Electrocardiographic abnormalities in patients with Cushing's syndrome.